Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Total Non-Current Liabilities (2016 - 2026)

Amphastar Pharmaceuticals has reported Total Non-Current Liabilities over the past 12 years, most recently at $810.5 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 3.3% year-over-year to $810.5 million; the TTM value through Dec 2025 reached $810.5 million, down 3.3%, while the annual FY2025 figure was $810.5 million, 3.3% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $810.5 million at Amphastar Pharmaceuticals, down from $882.5 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $933.8 million in Q3 2023 and troughed at $181.4 million in Q1 2021.
  • A 5-year average of $553.7 million and a median of $765.4 million in 2023 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: skyrocketed 350.37% in 2023 and later fell 15.35% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $210.4 million in 2021, then dropped by 2.02% to $206.1 million in 2022, then soared by 320.87% to $867.4 million in 2023, then dropped by 3.37% to $838.2 million in 2024, then dropped by 3.3% to $810.5 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for AMPH at $810.5 million in Q4 2025, $882.5 million in Q3 2025, and $830.1 million in Q2 2025.